These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 23266841)

  • 1. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: a potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints.
    Hsu J; Gu Y; Tan SL; Narula S; DeMartino JA; Liao C
    Immunol Lett; 2013 Feb; 150(1-2):97-104. PubMed ID: 23266841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a pharmacodynamic assay based on PLCγ2 phosphorylation for quantifying spleen tyrosine kinase (SYK)-Bruton's tyrosine kinase (BTK) signaling.
    Hsu J; Zhang J; Kitson C; Tan SL; Narula S; DeMartino JA; Liao C
    J Biomol Screen; 2013 Sep; 18(8):890-8. PubMed ID: 23704133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets.
    Zhang P; Solari FA; Heemskerk JWM; Kuijpers MJE; Sickmann A; Walter U; Jurk K
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.
    Rigg RA; Aslan JE; Healy LD; Wallisch M; Thierheimer ML; Loren CP; Pang J; Hinds MT; Gruber A; McCarty OJ
    Am J Physiol Cell Physiol; 2016 Mar; 310(5):C373-80. PubMed ID: 26659727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function.
    Zheng TJ; Lofurno ER; Melrose AR; Lakshmanan HHS; Pang J; Phillips KG; Fallon ME; Kohs TCL; Ngo ATP; Shatzel JJ; Hinds MT; McCarty OJT; Aslan JE
    Am J Physiol Cell Physiol; 2021 May; 320(5):C902-C915. PubMed ID: 33689480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.
    Xu D; Kim Y; Postelnek J; Vu MD; Hu DQ; Liao C; Bradshaw M; Hsu J; Zhang J; Pashine A; Srinivasan D; Woods J; Levin A; O'Mahony A; Owens TD; Lou Y; Hill RJ; Narula S; DeMartino J; Fine JS
    J Pharmacol Exp Ther; 2012 Apr; 341(1):90-103. PubMed ID: 22228807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
    Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
    Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2.
    Mayanglambam A; Dangelmaier CA; Thomas D; Damodar Reddy C; Daniel JL; Kunapuli SP
    Platelets; 2010; 21(3):211-20. PubMed ID: 20158382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.
    Fälker K; Klarström-Engström K; Bengtsson T; Lindahl TL; Grenegård M
    Cell Signal; 2014 Feb; 26(2):279-86. PubMed ID: 24240055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen.
    Quek LS; Bolen J; Watson SP
    Curr Biol; 1998 Oct; 8(20):1137-40. PubMed ID: 9778529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor.
    Polgár J; Clemetson JM; Kehrel BE; Wiedemann M; Magnenat EM; Wells TN; Clemetson KJ
    J Biol Chem; 1997 May; 272(21):13576-83. PubMed ID: 9153205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry.
    Cheung HYF; Moran LA; Sickmann A; Heemskerk JWM; Garcia Á; Watson SP
    Platelets; 2022 Nov; 33(8):1293-1300. PubMed ID: 35535424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation.
    Daniel JL; Dangelmaier CA; Mada S; Buitrago L; Jin J; Langdon WY; Tsygankov AY; Kunapuli SP; Sanjay A
    J Biol Chem; 2010 Jun; 285(23):17282-91. PubMed ID: 20400514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P; LaStant J; Keirstead N; Whittard T; Ayala J; Stefanova S; Garrido R; Dimaano N; Hilton H; Giron M; Lau KY; Hang J; Postelnek J; Kim Y; Min S; Patel A; Woods J; Ramanujam M; DeMartino J; Narula S; Xu D
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
    Denzinger V; Busygina K; Jamasbi J; Pekrul I; Spannagl M; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2019 Mar; 119(3):397-406. PubMed ID: 30685871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS; Theakston RD; Watson SP; Bon C; Laing GD; Zuzel M
    Arch Biochem Biophys; 2000 Feb; 374(2):356-62. PubMed ID: 10666318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for the regulation of Syk from agglutination to aggregation in human platelets.
    Shih CH; Chiang TB; Wang WJ
    Biochem Biophys Res Commun; 2014 Jan; 443(2):580-5. PubMed ID: 24326074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants.
    Hartkamp LM; Fine JS; van Es IE; Tang MW; Smith M; Woods J; Narula S; DeMartino J; Tak PP; Reedquist KA
    Ann Rheum Dis; 2015 Aug; 74(8):1603-11. PubMed ID: 24764451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of focal adhesion tyrosine kinases in GPVI-dependent platelet activation and reactive oxygen species formation.
    Carrim N; Walsh TG; Consonni A; Torti M; Berndt MC; Metharom P
    PLoS One; 2014; 9(11):e113679. PubMed ID: 25415317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM; Cambier JC
    J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.